GRIFFIN MICHELLE RENEE
SEC CIK 1229765 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ADPT | Adaptive Biotechnologies Corp | Dir | 67.7K | — | $3.02M | 17 | 2021-07-14 | 2026-06-25 |
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-29 19:49 | 2026-06-25 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $7.80 | +52.1K | 67.7K | +333% | +$406.3K |
| DT | 2026-06-29 19:49 | 2026-06-25 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $20.18 | -52.1K | 15.6K | -77% | -$1.05M |
| 2026-03-13 | 2026-03-11 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $13.91 | -15.4K | 15.6K | -50% | -$214.1K | |
| 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +15.6K | 31.0K | +102% | $0 | |
| D | 2026-03-05 | 2026-03-03 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $15.30 | -48.0K | 15.4K | -76% | -$735.1K |
| D | 2026-03-05 | 2026-03-03 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $3.99 | +48.0K | 63.4K | +312% | +$191.7K |
| 2025-03-17 | 2025-03-13 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $7.19 | -36.3K | 15.4K | -70% | -$260.9K | |
| D | 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +15.4K | 67.3K | +30% | $0 |
| D | 2025-03-06 | 2025-03-06 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $7.94 | -15.7K | 51.7K | -23% | -$124.4K |
| D | 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +31.3K | 52.0K | +152% | $0 |
| 2023-03-29 | 2023-03-27 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale | $8.49 | -2,341 | 20.6K | -10% | -$19.9K | |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +14.8K | 23.0K | +180% | $0 |
| D | 2022-01-28 | 2022-01-26 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
| D | 2021-08-30 | 2021-08-27 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $7.80 | +14.9K | 16.4K | +992% | +$116.3K |
| D | 2021-08-30 | 2021-08-27 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $35.00 | -14.9K | 1,504 | -91% | -$522.1K |
| D | 2021-07-19 | 2021-07-14 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | S - Sale+OE | $36.80 | -2,500 | 1,504 | -62% | -$92.0K |
| D | 2021-07-19 | 2021-07-14 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Dir | M - OptEx | $7.80 | +2,500 | 4,004 | +166% | +$19.5K |
Purchase Sale Sale after option exercise All abbreviations